Study on the Potential Mechanism of Fructus Tribuli in the Treatment of Hypertensive Vascular Remodeling Based on Network Pharmacology and Molecular Docking

Figure 8

Molecular docking between the major active compounds and main targets. (a) FT3 docking with VEGFA. (b) FT1 docking with VEGFA. (c) FT11 docking with VEGFA. (d) FT4 docking with MAPK3. (e) FT10 docking with VEGFA. (f) FT14 docking with AKT1. (g) FT6 docking with AKT1. (h) FT8 docking with MAPK3. (i) FT13 docking with VEGFA. (j) FT7 docking with MAPK3. (k) FT2 docking with VEGFA. (l) FT15 docking with SRC.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)